San Francisco, CA, United States of America

Carrie M Rosenberger

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Institute for Systems Biology. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carrie M Rosenberger. Retrieved from https://idiyas.com/inventor/carrie-m-rosenberger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pioneering Inventor Carrie M Rosenberger: Revolutionizing Antiviral Methods

Introduction: Carrie M Rosenberger, a brilliant inventor based in San Francisco, CA, has made significant contributions to the field of antiviral research with her groundbreaking patent.

Latest Patents: Carrie M Rosenberger holds a remarkable patent titled "Methods and compositions to modulate antiviral and immune activity responses." The patent focuses on an innovative method for manufacturing virus for use in vaccines by culturing infected cells that have been modified to overexpress miR-144. Additionally, the invention explores manipulating the activity or level of miR-144 in subjects to modulate antiviral and immune response systems effectively.

Career Highlights: Carrie M Rosenberger is associated with the Institute for Systems Biology, where her pioneering work in antiviral research has garnered recognition and praise. Her dedication to advancing medical technology and enhancing antiviral treatments showcases her commitment to innovation and progress in the field.

Collaborations: In her pursuit of excellence, Carrie M Rosenberger has collaborated closely with esteemed colleagues, including Alan Arnold Aderem. Together, they have worked tirelessly to push the boundaries of antiviral research and develop novel solutions for combating infectious diseases.

Conclusion: Inventor Carrie M Rosenberger's inventive spirit and dedication to advancing antiviral research shine through in her pioneering patent and collaborative efforts. Her contributions have the potential to revolutionize the field of antiviral methods, offering hope for more effective and targeted treatments in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…